NXL Stock Price, Nexalin Technology Inc Quote, Chart

Market Summary

USD1.32-0.01

Delayed

-0.75%

NXL Stock Price

View Fullscreen

NXL RSI Chart

NXL Valuation

Market Cap

9.8M

Price/Earnings (Trailing)

-1.99

Price/Sales (Trailing)

88.64

Price/Free Cashflow

-2.99

NXL Price/Sales (Trailing)

NXL Profitability

Operating Margin

74.96%

Return on Equity

-212.35%

Return on Assets

-174.35%

Free Cashflow Yield

-33.45%

NXL Fundamentals

NXL Revenue

Revenue (TTM)

110.7K

Rev. Growth (Yr)

112.73%

Rev. Growth (Qtr)

-2.64%

NXL Earnings

Earnings (TTM)

-4.9M

Earnings Growth (Yr)

-39.12%

Earnings Growth (Qtr)

-33.37%

Breaking Down NXL Revenue

Last 7 days

3.1%

Last 90 days

288.2%

Trailing 12 Months

67.1%

How does NXL drawdown profile look like?

NXL Financial Health

Current Ratio

5.05

NXL Investor Care

Shares Dilution (1Y)

2.06%

Diluted EPS (TTM)

-0.67

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	1.0M	716.1K	413.4K	110.7K
2022	438.4K	732.7K	1.0M	1.3M
2021	0	0	0	144.1K

Get all data in R, Python etc through our Historical Stock Data APIs

Which funds bought or sold NXL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	new	-	15,833	15,833	-%
May 15, 2024	CITADEL ADVISORS LLC	added	881	6,527	6,653	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	0.09	9,037	12,711	-%
May 15, 2024	BOOTHBAY FUND MANAGEMENT, LLC	unchanged	-	13,435	18,900	-%
May 15, 2024	ARMISTICE CAPITAL, LLC	unchanged	-	10,725	13,585	-%
May 15, 2024	Altium Capital Management LP	unchanged	-	3,465	4,389	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	new	-	4.00	4.00	-%
May 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	unchanged	-	39,768	54,412	-%
May 13, 2024	UBS Group AG	new	-	5,835	5,835	-%
May 13, 2024	UBS Group AG	reduced	-24.35	3.00	4.00	-%

Are Funds Buying or Selling NXL?

Are funds buying NXL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NXL

No. of Funds

Recent SEC filings of Nexalin Technology Inc

View All Filings

Date Filed	Form Type	Document
May 14, 2024	RW	RW
May 10, 2024	10-Q	Quarterly Report
Apr 26, 2024	8-K	Current Report
Apr 16, 2024	S-3	S-3
Apr 11, 2024	8-K	Current Report
Mar 27, 2024	10-K	Annual Report
Mar 20, 2024	8-K	Current Report

Peers (Alternatives to Nexalin Technology Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.13%	32.26%	-0.09	0.28	5.77%	8.23%

Nexalin Technology Inc News

Latest updates

Nexalin Technology Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)											(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Revenue	-2.6%	79.00	81.00	83.00	36.00	37.00	38.00	545	414	323	190	56.00
Cost Of Revenue	75.0%	9.00	5.00	4.00	9.00	7.00	7.00	187	123	46.00	-	9.00
Gross Profit	354.2%	70.00	15.00	20.00	26.00	23.00	32.00	358	291	277	-	47.00
Operating Expenses	-30.3%	1,143	1,640	2,436	903	803	751	651	736	652	-	1,842
S&GA Expenses	-43.9%	589	1,049	1,945	480	345	408	479	386	218	-	1,622
Interest Expenses	-100.6%	-304*	50.00	-5.33	-5.52	9.00	87.00	-10.45	-17.30	18.00	-	27.00
Net Income	-33.4%	-1,041	-780	-2,297	-822	-748	-729	-135	-439	-393	-595	-1,799
Net Income Margin	-6.3%	-44.62*	-41.98*	-11.12*	-3.40*	-2.02*	-1.28*	-1.52*	-4.41*	-11.15*	-42.19*	-
Free Cashflow	24.0%	-763	-1,004	-701	-815	-1,314	-906	-943	-162	-203	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet								(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2021Q4
Assets	-22.0%	2,834	3,632	4,434	5,176	5,930	7,432	8,353	754
Current Assets	-25.3%	2,563	3,430	4,263	5,112	5,876	7,425	8,345	753
Cash Equivalents	-5.9%	546	580	361	232	175	163	7,864	662
Inventory	-1.8%	154	156	159	160	158	154	152	31.00
Net PPE	-	-	-	100*	234*	368*	503*	636*	1.00
Liabilities	19.3%	507	425	1,197	1,183	1,195	1,953	1,998	2,436
Current Liabilities	19.3%	507	425	1,197	1,183	1,195	1,949	1,980	2,364
Shareholder's Equity	-27.4%	2,327	3,207	3,237	3,993	4,735	5,479	6,355	-1,681
Retained Earnings	-1.4%	-78,079	-77,038	-76,257	-73,960	-73,137	-72,389	-71,659	-70,691
Additional Paid-In Capital	0.2%	80,399	80,238	79,486	77,913	77,824	77,824	78,007	69,005
Accumulated Depreciation	-100.0%	-	3.00	3.00	2.00	2.00	2.00	30.00	30.00
Shares Outstanding	0%	7,437	7,437	7,437	7,287	7,287	7,287	4,995	4,880
Float	-	-	-	-	4,994	-	-	23,477	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)											(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Cashflow From Operations	24.0%	-763	-1,004	-701	-815	-1,314	-906	-943	-162	-203	-	-
Share Based Compensation	-78.5%	161	752	1,573	88.00	-	-182	184	172	98.00	-	-
Cashflow From Investing	-40.4%	729	1,223	831	872	1,527	-	-	-	-	-	-
Cashflow From Financing	-	-	-	-	-	-200	-	8,516	-5.00	100*	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NXL Income Statement

2024-03-31

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues, net (Includes related party of $300 and $0 for the three months ended March 31, 2024 and March 31, 2023, respectively)	$ 78,671	$ 30,560
Cost of revenues	9,156	7,110
Gross profit	69,515	23,450
Operating expenses:
Professional fees	227,829	158,600
Salaries and benefits	326,417	299,323
Selling, general and administrative	588,981	344,953
Total operating expenses	1,143,227	802,876
Loss from operations	(1,073,712)	(779,426)
Other income (expense), net:
Interest income (expense), net	304	(8,837)
Gain on sale of short-term investments	24,946	38,772
Other income	1,522	1,077
Total other income (expense), net	26,772	31,012
Loss before equity in net earnings of affiliate	(1,046,940)	(748,414)
Equity in net earnings of affiliate	5,783
Net loss	(1,041,157)	(748,414)
Other comprehensive income (loss):
Unrealized gain from short-term investments	160	41,069
Comprehensive loss	$ (1,040,997)	$ (707,345)
Net loss per share attributable to common stockholders - Basic	$ (0.14)	$ (0.10)
Net loss per share attributable to common stockholders - Diluted	$ (0.14)	$ (0.10)
Weighted Average Shares Outstanding - Basic	7,436,562	7,286,562
Weighted Average Shares Outstanding - Diluted	7,436,562	7,286,562

NXL Balance Sheet

2024-03-31

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 546,255	$ 580,230
Short-term investments	1,597,687	2,368,203
Accounts receivable (Includes related party of $100 and $3,614, respectively)	3,666	9,369
Inventory	153,668	156,420
Prepaid expenses and other current assets	261,977	315,670
Total Current Assets	2,563,253	3,429,892
ROU Asset		496
Intangible assets, net	169,174	105,528
Equity method investment	101,783	96,000
Total Assets	2,834,210	3,631,916
Current Liabilities:
Accounts payable	151,510	159,534
Accrued expenses	355,713	261,284
Lease liability, current portion		4,463
Total Current Liabilities	507,223	425,281
Total Liabilities	507,223	425,281
Stockholders’ Equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 7,436,562 shares issued and outstanding at March 31, 2024 and December 31, 2023	7,437	7,437
Accumulated other comprehensive income (loss)	(245)	(405)
Additional paid in capital	80,399,001	80,237,652
Accumulated deficit	(78,079,206)	(77,038,049)
Total Stockholders’ Equity	2,326,987	3,206,635
Total Liabilities and Stockholders’ Equity	$ 2,834,210	$ 3,631,916

About Nexalin Technology Inc

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

CEO	Mr. Mark White
WEBSITE	nexalin.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	6

Nexalin Technology Inc Frequently Asked Questions

What is the ticker symbol for Nexalin Technology Inc? What does NXL stand for in stocks?

NXL is the stock ticker symbol of Nexalin Technology Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nexalin Technology Inc (NXL)?

As of Fri May 17 2024, market cap of Nexalin Technology Inc is 9.82 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NXL stock?

You can check NXL's fair value in chart for subscribers.

What is the fair value of NXL stock?

You can check NXL's fair value in chart for subscribers. The fair value of Nexalin Technology Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nexalin Technology Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NXL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nexalin Technology Inc a good stock to buy?

The fair value guage provides a quick view whether NXL is over valued or under valued. Whether Nexalin Technology Inc is cheap or expensive depends on the assumptions which impact Nexalin Technology Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NXL.

What is Nexalin Technology Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NXL's PE ratio (Price to Earnings) is -1.99 and Price to Sales (PS) ratio is 88.64. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NXL PE ratio will change depending on the future growth rate expectations of investors.